WO2019235637A2 - Seringue ayant une aiguille de seringue mobile et aiguille à pointe pour douleur de camouflage - Google Patents

Seringue ayant une aiguille de seringue mobile et aiguille à pointe pour douleur de camouflage Download PDF

Info

Publication number
WO2019235637A2
WO2019235637A2 PCT/JP2019/022835 JP2019022835W WO2019235637A2 WO 2019235637 A2 WO2019235637 A2 WO 2019235637A2 JP 2019022835 W JP2019022835 W JP 2019022835W WO 2019235637 A2 WO2019235637 A2 WO 2019235637A2
Authority
WO
WIPO (PCT)
Prior art keywords
gasket
needle
syringe
container body
plunger
Prior art date
Application number
PCT/JP2019/022835
Other languages
English (en)
Japanese (ja)
Other versions
WO2019235637A3 (fr
Inventor
義夫 大山
Original Assignee
北川 正人
菅野 博人
森下 裕道
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 北川 正人, 菅野 博人, 森下 裕道 filed Critical 北川 正人
Priority to JP2020523215A priority Critical patent/JPWO2019235637A1/ja
Publication of WO2019235637A2 publication Critical patent/WO2019235637A2/fr
Publication of WO2019235637A3 publication Critical patent/WO2019235637A3/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles

Definitions

  • the present invention relates to a syringe having an injection needle, and relates to one in which the injection needle moves and is exposed and pulled back, and one having a camouflaged pain point needle different from the injection needle.
  • the oral route is most commonly used for daily drug administration. If there is no mistake in the selection and dispensing of the medicine and the timing of ingestion is not wrong, there will be few major mistakes, and it can be said that it is a convenient, simple and safe administration method compared to the injection route. Therefore, in the home treatment, the current situation is to entrust oral administration of pharmaceuticals to individual patients. Examples of dosage forms used include tablets, capsules, and powders.
  • the drug when administered orally, the drug is absorbed by the digestive organs such as the stomach and small intestine, so this drug may cause gastrointestinal damage or the drug may be degraded by gastric acid in the digestive tract (especially the stomach). .
  • this drug may cause gastrointestinal damage or the drug may be degraded by gastric acid in the digestive tract (especially the stomach).
  • gastric acid especially the stomach.
  • the absorption of the drug differs depending on the state of the digestive tract.
  • the injection route is particularly effective in the case of a medicine that is not decomposed in the digestive tract or the like or is not absorbed in the digestive tract or the like.
  • routes of administration such as intravenous, intramuscular, subcutaneous, and intradermal.
  • the injection route allows the drug to be administered directly to the necessary site (affected area), so the time until the start of the effect is shorter than other administration methods, and it is filtered during the absorption process. It can be said to be a more reliable method because it can be administered even if it is denatured or decomposed by detoxification during the absorption process.
  • the administration method by the injection route is superior to the oral route. Due to its effectiveness, self-injection is permitted even in countries where injection is limited to medical practice by doctors (such as Japan). Examples of use include insulin injection for diabetes treatment, heparin injection for infertility prevention, blood coagulation factor drug self-injection for hemophilia treatment, and the like.
  • a needleless syringe without a needle has been considered as a solution to some of the above problems, but it is expensive, the impact sound is too loud when discharging a chemical solution, and secondary infection caused by reusing an expensive injector It is not popular for reasons such as.
  • the present invention has been made in view of the above points, and its purpose is to eliminate the dangers of hygiene and precautions before and after use because of excellent handling of the injection needle, and to prevent the invasion by the injection needle even during use.
  • An object of the present invention is to provide a syringe capable of wiping off.
  • the present invention provides the following.
  • (1) It has a hollow cylindrical container body and a protective body that closes one end side of the container body and is connected to the inside and outside of the container body, and the protective body is an injection arranged in the container body.
  • a syringe having a needle hole for protecting the needle.
  • the syringe has a protective body that closes one end side of the container body, is formed continuously with the inside and outside of the container body, and has a needle hole portion that protects the injection needle.
  • the injection needle is accommodated and protected in the needle hole portion in the body. Since the injection needle is housed in the container body by the protective body and one end side is closed, the injection needle is not exposed to the open air until it is actually used, and the hygiene of storing the syringe and the injection needle Excellent management.
  • the protective body can be formed integrally with the container body so that it can be easily separated, or can be mounted separately from the container body (for example, a cap).
  • the needle hole is formed in the container body so that the syringe needle is accommodated in the container body and the injection needle is not exposed outside the container body even if separated from the protective body.
  • a syringe characterized in that a protrusion projecting from the tip surface is formed at the tip of one end of the container body.
  • the protruding portion when inoculating the tip surface in contact with the skin, presses the skin and can give a pain different from the pain of needle stick, making it difficult to feel the original pain of injection. be able to.
  • This protrusion functions as a so-called camouflaged pain point needle, and disguises pain such that another needle is inserted around the needle.
  • the bottom surface of the needle hole portion is located above the distal end surface of the container main body, the state in which the injection needle is accommodated in the container main body can be maintained before use. There is no concern of damaging the skin and the skin before, and the danger of lurking in handling the injection needle can be avoided.
  • the protector includes a tip portion protruding from a tip surface of the container main body, and a gasket receiving portion in which the needle hole portion is formed, and the tip portion, the gasket receiving portion, and the container main body.
  • a connecting part for connecting the container body, the connecting part is broken by applying a force to the tip part, and the container body and the protective body can be separated. Syringe.
  • a force is applied to the tip portion by rotating or folding around the central axis, whereby the connecting portion is broken, and the container body and the protective body (tip portion and gasket receiving portion) are separated by cleavage. Since it is possible, the injection needle can be kept sealed until it is used, contamination of the syringe and the injection needle can be avoided, and the hygiene management is excellent.
  • the cross section can be formed into a flat cross section without unevenness. Thereby, even if it strongly presses a connection part (cut surface) to skin, safety
  • security can be ensured, without damaging skin by a cut surface.
  • the gasket with the needle is disposed in the gasket receiving portion, the gasket with the needle supported by the gasket receiving portion is in a state of being accommodated in the container body. Even after the protective part (gasket receiving part) is removed by removing the cap or cleaving, the needle-attached gasket is still in contact with the inner peripheral surface of the container body, so that the injection needle is still housed in the container body. Therefore, there is no fear of damaging the skin and the skin before use, and the danger of lurking in the handling of the injection needle can be avoided. Furthermore, since the injection needle is housed in the container body, the patient does not see the injection needle before and after use and during use, thus reducing mental stress such as giving fear to the patient. Can do.
  • the syringe with the needle gasket having an introduction path for guiding the chemical solution to the injection needle and having a partition wall in the introduction path as a contact surface with the chemical solution.
  • the upstream side where the chemical liquid is filled in the introduction path and the downstream side where there is no chemical liquid by the gasket with the needle that has the introduction path and has a partition wall that becomes a contact surface with the chemical liquid in the introduction path The medicine solution can be prevented from easily flowing into the injection needle.
  • the gasket with the needle moves immediately before the inoculation, but in order to prevent the unintentional release of the chemical solution from the injection needle before the inoculation with this movement, the chemical solution that has broken or penetrated the septum by applying a predetermined pressure Flows into the needle.
  • this partition is unnecessary.
  • the degree to which the chemical solution breaks or penetrates the partition wall can be controlled by the partition wall having the cut.
  • the number of cuts, depth, shape, etc. may be set according to the properties of the chemical (viscosity, etc.).
  • the degree of penetration through fracture can be controlled by providing the partition wall with a mechanism through fracture.
  • the movable gasket with the needle since it has an inner wall portion that is located above the one end side of the container body and protrudes in the inner circumferential direction, the movable gasket with the needle cannot move below the inner wall portion. It serves as a stopper for the attached gasket. Thereby, by restricting the movable range of the gasket with the needle and appropriately designing the length of the injection needle, it is possible to prevent the injection needle from penetrating the skin excessively. That is, the injection needle can be penetrated to an appropriate depth for each of intradermal injection, subcutaneous injection, intramuscular injection, and the like, which can contribute to selection of a syringe according to an application site such as an injection location and depth.
  • a syringe having a gasket at the tip which is in contact with the inner peripheral surface of the container body and having a plunger disposed on the other end side of the container body.
  • the plunger is arranged on the other end side of the container main body, and the container main body keeps the closed state at both ends by the plunger and the protector to block contact with the outside air. Excellent in hygiene management of syringes. Further, even if the plunger is pulled back, only the gasket remains in the container body, so that it is impossible to re-inject the drug solution into the syringe, and the syringe can be prevented from being reused.
  • the gasket and the plunger are connected by a connecting body, and the connecting body moves the gasket in accordance with the pressing operation of the plunger, and is detached from the gasket in accordance with the pulling-out operation of the plunger.
  • a syringe characterized by that.
  • the gasket and the plunger are connected by the connecting body, and the connecting body moves the gasket in accordance with the pressing operation of the plunger. Therefore, the plunger and the gasket are pressed through the connecting body. Move to the bottom of the container body.
  • the plunger is detached from the gasket as the plunger is pulled out, the plunger and the gasket are separated, and only the plunger is pulled out of the container body, and the gasket stays in the container body. Thereby, since it becomes impossible to refill a chemical
  • the gasket with the needle is also sucked with the movement of the plunger or directly and pulled back into the container body. Will be.
  • the injection needle is similarly pulled back into the container body, the skin and the skin are not damaged by the used injection needle, and the danger hidden in the handling of the injection needle can be avoided.
  • the present invention it is possible to avoid problems such as a selection mistake of a medicine to be injected and a mistake in inoculation amount by filling the container body with a necessary chemical solution (completely virgin type prefilled). Furthermore, it is preferable to clarify the indication of which medicine is filled in which amount.
  • the gasket can be removed from the gasket, making it impossible to replace the already filled chemical without permission, preventing accidents and mistakes at the medical site, and reusing the syringe and needle. It can also contribute to prevention.
  • a syringe characterized in that a storage portion for storing an anesthetic is provided at the rear end of the plunger.
  • the storage portion for storing the anesthetic is provided at the rear end of the plunger, the anesthetic can be applied to or attached to the skin before inoculation, so that pain during inoculation can be alleviated.
  • the syringe of the present invention avoids and solves the problems inherent in conventional syringes (the danger of lurking in the handling of injection needles, the mistake of drugs introduced into the syringe, and the occurrence of pain during use), and the application site for hygiene management There is an effect that an excellent syringe can be provided.
  • FIG. 1A is an exploded view of the syringe according to the embodiment of the present invention
  • FIG. 1B is a view of the plunger 4 as viewed from above
  • FIG. 2 is according to the embodiment of the present invention. It is an assembly drawing of a syringe. 1 and 2, the syringe is composed of a syringe barrel 1, a needle-attached gasket 2, and a plunger 4 to which a gasket 3 is attached.
  • the syringe barrel 1 is integrally formed with a hollow cylindrical container body 11 and a protective body 12 that closes the lower end side (one end side) of the container body 11.
  • the container main body 11 has a ring-shaped upper handle 11a on the upper end side, a ring-shaped lower handle 11b on the slightly upper side, and two protrusions 11 C1 and 11 C2 on the lower end (one end). And a ring-shaped inner wall portion 11 d that protrudes in the center direction from the inner wall surface of the container main body 11.
  • the number of protrusions is not limited to two. One or more may be sufficient.
  • the shape is not particularly limited, such as a cylinder, a prism, a cone or a pyramid. When pressed strongly against the epidermis, the surface should be sharp (dull) to the extent that it does not damage and feel a pressure and mild pain.
  • the protector 12 integrally formed with the container main body 11 is formed with a knob portion 12a, a gasket receiving portion 12b, and a needle hole portion 12c formed in the gasket receiving portion 12b. Furthermore, a ring-shaped connecting portion 13 that connects the container body 11 and the protective body 12 is formed.
  • the protection body 12 is a cap type
  • the lower end (one end) of the container body 11 functions as the connection portion 13, and the connection by the connection portion 13 is released by rotating the cap, so that the container body 11 and the protection body 12 are released. And can be separated.
  • the container body 11 and the protection body 12 can be separated by applying a force such as twisting or folding to the knob part 12a, and the connecting part 13 is broken.
  • the container main body 11 and the protective body 12 are integrally formed, the lower end surface 11e of the container main body 11 and the upper end surface 12d of the knob portion 12a of the protective body 12 are formed in different directions, so that the connecting portion 13 By forming a thin film, it is possible to reduce the force required for cleavage, and to reduce the cleavage plane (connecting portion 13) generated by cleavage.
  • the separated cleaved surface (connecting portion 13) surface has no unevenness, and when the tip of the syringe 1 is pressed against the skin before taking out the injection needle, the connecting portion The risk of damaging the skin is eliminated by the 13 separate surfaces. Therefore, when the syringe 1 is pressed vertically against the skin, the broken and separated connecting portion 13 can be pressed firmly against the skin, and the cross section can be kept in contact with the skin surface.
  • the depth of insertion can be defined to be constant. That is, the depth at which the injection needle 22 is inserted, such as subcutaneous injection or intramuscular injection, can be defined to a desired depth. On the other hand, the depth at which the injection needle 22 is inserted is not constant on the cut surface having the connecting portion 13 with severe irregularities, and ideal injection is impossible on the cut surface that damages the epidermis.
  • the cleaving material is composed of a known resin composition having a number average molecular weight of 1 ⁇ 10 3 to 1 ⁇ 10 6 obtained by polymerizing hydrogen, methyl, fluorine or the like.
  • a material having high crystallinity is likely to cause broken pieces, and a material having excellent malleability and ductility such as PET has a problem that burrs and swells are likely to occur without being damaged, whereas a resin composition has an appropriate hardness. Clean breakage can be expected, and breakage can be prevented from occurring.
  • the needle-equipped gasket 2 has a gasket 21 and an injection needle 22.
  • a hollow cylindrical upper ring portion 21a, a coaxial hollow cylindrical middle ring portion 21b, and a coaxial hollow cylindrical lower ring portion 21c are integrally formed.
  • the outer ring diameter of the upper ring portion 21a is substantially the same as the inner wall diameter of the container body 11, and prevents the chemical solution 5 filled in the container body 11 from flowing downward.
  • the hollow portion of the upper ring portion 21 a is formed with an introduction path 21 d for guiding the drug solution 5 to the injection needle 22.
  • This introduction path 21d has a shape in which the tip tapers as it goes downstream.
  • the hollow portions of the middle ring portion 21b and the lower ring portion 21c are formed with an injection needle hole 21e for inserting and fixing the injection needle 22, and the injection needle 22 is inserted into the injection needle hole 21e.
  • the introduction path 21d and the injection needle hole 21e communicate with each other and are integrally formed.
  • the outer diameter of the lower ring 21c is substantially the same as the inner wall diameter of the container body 11 and, together with the upper ring portion 21a, prevents the chemical solution 5 filled in the container body 11 from flowing out downward. Yes. Further, the outer peripheral diameter of the middle ring portion 21b is smaller than that of the upper ring portion 21a and the lower ring portion 21c and smaller than the inner wall diameter of the container body 11, thereby reducing the sliding friction caused by the movement of the needle-attached gasket 2. Yes.
  • the gasket 3 includes a hollow cylindrical upper ring portion 31a, a coaxial hollow cylindrical middle ring portion 31b, and a coaxial hollow cylindrical lower ring portion 31c that are integrally formed.
  • the upper ring portion 31 a has an outer diameter that is substantially the same as the inner wall diameter of the container body 11, and the medicine liquid 5 filled in the container body 11 flows upward or downwards when the syringe is turned upside down. Is prevented.
  • the outer diameter of the lower ring 31c is substantially the same as the inner wall diameter of the container body 11, and together with the upper ring portion 31a, the drug solution 5 filled in the container body 11 is flowed upward or injected. The chemical solution 5 is prevented from flowing downward when it is turned upside down.
  • the outer ring diameter of the middle ring portion 31b is smaller than that of the upper ring portion 31a and the lower ring portion 31c, and smaller than the inner wall diameter of the container body 11, thereby reducing the sliding friction caused by the movement of the gasket 3.
  • the upper ring portion 31a and the middle ring portion 31b of the gasket 3 are integrally formed with communicating hollow portions 31d and 31e, the hollow portion 31d having a small diameter and the hollow portion 31e having a large diameter region. That is, the connecting body 41c inserted into the hollow portion can be moved with play in the large diameter region, and the gasket 3 can be moved downward as the plunger 4 is pressed.
  • the plunger 4 includes a disc-shaped handle portion 41a and a cylindrical or columnar plunger main body portion 41b which are integrally formed, and a connecting body 41c having a T-shaped cross section at the lower end of the plunger main body portion 41b. Is connected.
  • the connecting body 41c is inserted into the upper ring portion 31a and the middle ring portion 31b of the gasket 3.
  • the gasket 3 and the plunger 4 are weakly fitted or not fitted, and the plunger 4 is easily separated from the gasket 3 so that the gasket 3 left in the container body 11 is movable. I can't do it. This prevents the chemical solution from being refilled between the gasket 2 with a needle and the gasket 3.
  • the connection body 41c that connects the gasket 3 and the plunger 4 is easily separated from the gasket 3 so that the gasket 3 left in the container body 11 cannot be moved.
  • the syringe including the syringe barrel 1, the needled gasket 2, and the plunger 4 to which the gasket 3 is attached is used after being assembled and manufactured as follows.
  • the gasket 2 with a needle is inserted into the container body 11 of the syringe barrel 1 from the upper end of the opening and is brought into contact with the gasket receiving portion 12b. At this time, the injection needle 22 is accommodated in the needle hole portion 12c.
  • the plunger 4 to which the gasket 3 is attached is attached in a state where the specified amount of the chemical solution 5 is filled in the container body 11 of the syringe barrel 1.
  • FIG. 3 is a schematic view showing another example of the gasket 2 'with a needle, (A) is a cross-sectional view, and (B) is a cross-sectional view along AA.
  • the illustration of the injection needle 22 is omitted.
  • the needle-attached gasket 2 ' may be used in the second, third, and fourth syringes.
  • the gasket 2 'with a needle is integrally formed with a hollow cylindrical upper ring portion 21a, a coaxial hollow cylindrical middle ring portion 21b, and a coaxial hollow cylindrical lower ring portion 21c.
  • the outer diameter of each ring part is the same as that of the gasket 2 with a needle.
  • the introduction path 21d is formed in the middle of the upper ring portion 21a and the middle ring portion 21b, and the injection needle hole 21e is formed in the middle of the middle ring portion 21b and the lower ring portion 21c.
  • a U-shaped chemical stopper 23 is inserted in contact with the outer peripheral wall 23b, and the introduction path 21d is vertically divided by the upper surface disk 23a.
  • the upper surface disk 23a is formed with a symmetric cut line 23c at the center of the circle, and controls the outflow of the chemical solution from the upstream to the downstream in the introduction path 21d.
  • the upper surface disk 23a uses soft rubber as a raw material, and has a role of preventing the medicinal solution 5 from passing through the injection needle 22 until a certain amount of internal pressure is applied to the soft rubber film having a cut. This prevents a small amount of the drug solution 5 from being released before the needle tip of the injection needle 22 pierces the skin if the viscosity of the drug solution 5 to be included is low when the gasket 3 moves forward.
  • human skin is composed of the epidermis, dermis, and subcutaneous tissue from the outside, and muscles and veins are located in the subcutaneous tissue and further back.
  • the reason why pain is felt when the needle is inserted into the skin is said to be that the needle hits the pain points distributed on the skin surface, and it is said that 100 to 200 pain points are distributed per 1 cm 2 .
  • the pain of the injection needle can be alleviated by applying a patch containing a local anesthetic containing lidocaine or applying a cream or the like.
  • FIG. 4 is a diagram for explaining the operation of the protrusion.
  • the pain due to the protrusions 11 C1 and 11 C2 is given to the skin. Yes.
  • another pain is given by the protrusions 11 C1 and 11 C2, thereby accustoming to another pain.
  • the number of protrusions is not limited to two, and can be increased depending on the degree of pain.
  • FIG. 5 is an assembly diagram of a syringe using the plunger 4 with the spring body, and the spring body 6 is arranged on the outer peripheral surface of the plunger main body 41b.
  • FIG. 5A is a view showing a state before use, and the spring body 6 is extended.
  • FIG. 5B is a diagram showing a state in use. In a state where the plunger 4 is pushed down to expose the injection needle 22 from the syringe barrel 1, the spring body 6 is contracted.
  • FIG. 5C is a diagram showing a state after use, and the spring body 6 is restored and is about to extend.
  • the spring body 6 is an elastic member that generates a restoring force that is opposite to the pressing direction, and is formed of a metal such as aluminum or stainless steel or a resin.
  • the syringe 3 having such a spring body 6 automatically moves the gasket 3 by the restoring force without performing the operation of pulling up the plunger 4, and the needle-attached gasket 2 is sucked by the accompanying load pressure in the container body 11.
  • the injection needle 22 enters the syringe barrel 1 as it is pushed up.
  • FIG. 6 is an exploded view of another syringe according to the embodiment of the present invention
  • FIG. 7 is an assembly view of another syringe according to the embodiment of the present invention.
  • the syringe shown in FIG. 5 is similar to the syringe 1, the gasket 2 with the needle, and the plunger 4 to which the gasket 3 is attached.
  • the shape of the gasket receiving part 12b of the protection body 12 of the injection cylinder 1 is different, it is because of convenience when the spring body 6 is disposed on the outer peripheral surface of the plunger receiving part 12b.
  • FIG. 8 is an exploded view of another syringe according to the embodiment of the present invention
  • FIG. 9 is an assembly view of another syringe according to the embodiment of the present invention.
  • the basic configuration of the needle-attached gasket 2 is the same as that of the syringe of FIG.
  • the container body 11 of the syringe barrel 1 does not have a ring-shaped upper and lower handle.
  • the plunger 7 to which the gasket 3 is attached includes an outer wall portion 71a, a plunger main body portion 71b that is linked with the outer wall portion 71a and spaced apart by a predetermined gap, and a lower end of the plunger main body portion 71b.
  • a connecting body 71c having a T-shaped cross section is connected.
  • the spring body 6 is disposed in a gap formed between the plunger main body 71b and the outer wall 71a.
  • the upper end of the spring body 6 is on the upper surface of the outer wall 71a, and the lower end of the spring body 6 is on the opening of the container main body 11. Located on the end face.
  • the gasket 3 is automatically moved by the restoring force of the spring body 6 without performing the operation of pulling up the plunger 7, and the gasket 2 with a needle is pushed up by the accompanying load pressure in the container body 11. Then, the injection needle 22 enters the syringe barrel 1.
  • FIG. 10 is an exploded view of another syringe according to the embodiment of the present invention
  • FIG. 11 is an assembly view of another syringe according to the embodiment of the present invention.
  • the syringe with needle 2 is the same as the syringe of FIG. 5,
  • the configuration of the syringe barrel 1 is the same as the syringe of FIGS. 6 and 7, and the configuration of the plunger 7 is the same as the syringe of FIGS. Is the same.
  • FIG. 12 is a view for explaining the storage portions 42 and 72 for storing the anesthetic 8, and is an upper portion of the handle portion 41 a located at the rear end of the plunger 4 or an outer wall portion located at the rear end of the plunger 7. Box-shaped storage portions 42 and 72 are provided on the upper portion of 71a.
  • the anesthetic 8 is sealed in a sealed container. When the anesthetic 8 is used, the container is taken out from the storage portions 42 and 72 and applied to the skin for surface anesthesia.
  • the anesthetic 8 may be a patch type or a cream type, and is taken out from the storage portions 42 and 72 and applied or applied. Even if the storage portions 42 and 72 are not provided separately, the rear end surfaces of the plungers 4 and 7 are adhered to the storage portions 42 72 may function.
  • FIGS. 13A and 14A show a state before use.
  • FIGS. 13A and 14A show a state where the protective body 12 is removed. From (A) to (B), a storage portion 42 for storing the anesthetic 8 is provided at the tip of the handle portion of the plunger 4, and a hole is made in the storage portion 42 immediately before use of the syringe. Apply anesthetic 8 to the affected area.
  • FIG. 15 (A) shows such a state.
  • FIGS. 13C and 14C show a state in which the plunger 4 is pushed in and the injection needle 22 is exposed. From (B) to (C), the surface of the container body 11 is brought into contact with the skin after the surface anesthesia, so that the protrusions 11 C1 and 11 C2 located at the tip are shallowly cut into the skin and the protrusion is stuck. Makes the brain feel. In addition, in the step of gradually piercing the needle in (C), the injection needle 22 is inserted into the skin while the illusion that the protrusion is stuck and hurts.
  • FIG. 13 (D) and FIG. 14 (D) show a state in which the drug solution 5 is injected into the subcutaneous tissue.
  • FIG. 15 (B) shows this state, and the chemical solution 5 is applied to the subcutaneous tissue (about 2.3 mm below the skin surface) located below the epidermis (about 0.2 to 0.3 mm) and the dermis (about 2 mm). Inject.
  • FIGS. 13 (E) and 14 (E) show a state in which all of the chemical liquid 5 has been injected.
  • the gasket 3 and the gasket with needle 2 are in contact with each other.
  • FIGS. 13 (F) and 14 (F) show a state in which the plunger 4 is removed from the syringe barrel 1. From (E) to (F), the needle-attached gasket 2 having the injection needle 22 is pulled back by the restoring force of the spring 6 and stored in the main body container 11. If the plunger 4 is pulled strongly upward, the plunger 4 and the needle-attached gasket 3 are disconnected, and the needle-attached gasket 3 is left in the syringe barrel 1. In the state (F), the syringe cannot be reused by re-injecting the drug solution between the gasket 4 and the needle-attached gasket 3.
  • the syringe according to the present invention is useful as anyone that can be safely and easily used by anyone.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La présente invention vise à fournir une seringue qui a une aiguille de seringue conviviale, apaise les craintes liées à l'hygiène et au danger avant et après l'utilisation, et apaise l'anxiété liée à l'invasivité de l'aiguille d'injection même pendant l'utilisation. L'invention concerne par conséquent une seringue comprenant un corps de seringue (1), un joint d'étanchéité équipé d'aiguille (2), et un plongeur (4) sur lequel est monté un joint d'étanchéité (3). Dans le cylindre d'injection (1), un corps de récipient (11) et un corps de protection (12) sont formés d'un seul tenant, et le corps de protection (12) est séparé d'une partie de raccordement (13) en étant clivé avant utilisation. Une aiguille d'injection (22) est logée dans le corps de récipient (11), et en actionnant le plongeur (4) au moment de l'utilisation, l'aiguille d'injection (22) est exposée à l'extérieur du corps de récipient (11) et inocule la peau. De ce fait, deux parties en saillie 11C1, 11C2 à la pointe du corps de récipient (11) sont mises en contact avec la peau pour presser l'épiderme et le derme jusqu'à un degré tel que l'épiderme et le derme ne sont pas endommagés, une douleur autre que la douleur provenant de l'aiguille d'injection (22) étant provoquée et la douleur provenant de l'aiguille d'injection (22) étant ainsi camouflée et réduite. Après utilisation, le joint d'étanchéité équipé d'aiguille (2) est renvoyé à l'intérieur du corps de récipient (11) et l'aiguille d'injection est logée à l'intérieur de celui-ci.
PCT/JP2019/022835 2018-06-08 2019-06-08 Seringue ayant une aiguille de seringue mobile et aiguille à pointe pour douleur de camouflage WO2019235637A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020523215A JPWO2019235637A1 (ja) 2018-06-08 2019-06-08 可動式注射針及び偽装痛点針を有する注射器

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018110050 2018-06-08
JP2018-110050 2018-06-08

Publications (2)

Publication Number Publication Date
WO2019235637A2 true WO2019235637A2 (fr) 2019-12-12
WO2019235637A3 WO2019235637A3 (fr) 2020-01-30

Family

ID=68770427

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2019/022835 WO2019235637A2 (fr) 2018-06-08 2019-06-08 Seringue ayant une aiguille de seringue mobile et aiguille à pointe pour douleur de camouflage

Country Status (2)

Country Link
JP (1) JPWO2019235637A1 (fr)
WO (1) WO2019235637A2 (fr)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3552387A (en) * 1968-07-16 1971-01-05 Peter A Stevens Combination syringe and vial
EP1242132B1 (fr) * 1999-12-23 2003-10-15 Arnold Neracher Dispositif d'injection et systeme de propulsion associe
DE102005054075A1 (de) * 2005-11-12 2007-05-16 Vetter & Co Apotheker Kanülenaufsatz für eine Spritze oder Karpule
WO2012147408A1 (fr) * 2011-04-28 2012-11-01 テルモ株式会社 Ensemble-aiguille hypodermique et dispositif d'injection d'un médicament
WO2015064031A1 (fr) * 2013-10-31 2015-05-07 南部化成株式会社 Aiguille d'injection de solution de médicament et dispositif d'administration de médicament transdermique
EP3226957B1 (fr) * 2014-12-03 2022-02-02 623 Medical, LLC Distributeur
US10166342B2 (en) * 2015-01-21 2019-01-01 West Pharmaceutical Services, Inc. Recoil reducing needle shields
JP2018507732A (ja) * 2015-03-10 2018-03-22 ヒンド ラソア，ジャイ 流体注入システムとその方法
TW201731548A (zh) * 2015-11-27 2017-09-16 賽諾菲阿凡提斯德意志有限公司 用於注射裝置的部件、系統和方法
US20180369499A1 (en) * 2015-12-15 2018-12-27 Iinjec Technologies Inc. / Les Technologies Iinjec Inc. Syringes with retractable needle

Also Published As

Publication number Publication date
WO2019235637A3 (fr) 2020-01-30
JPWO2019235637A1 (ja) 2021-09-09

Similar Documents

Publication Publication Date Title
US10857308B2 (en) Injection apparatus with needle housing for desensitising skin
US9682198B2 (en) Intradermal injection device
US11701476B2 (en) Cap for medical injector
US7815610B2 (en) Injection apparatus
JP2011235108A (ja) 使い捨て可能で両端が尖った注射針
JP2008504928A (ja) 使い捨て注射器
JP4955010B2 (ja) 劈開により簡便に美麗な開口面を得ることができる機構及び可動ガスケットを有するアンプル
EP3386571B1 (fr) Capuchon en t pour injecteur médical
WO2009031144A1 (fr) Enveloppe contenant une aiguille stérile
WO2019235637A2 (fr) Seringue ayant une aiguille de seringue mobile et aiguille à pointe pour douleur de camouflage
CN112312945A (zh) 用于注射药物的装置及使用方法
KR100761095B1 (ko) 치과용 주사바늘
WO2021044776A1 (fr) Dispositif d'injection automatique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19814355

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2020523215

Country of ref document: JP

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 19814355

Country of ref document: EP

Kind code of ref document: A2